Unconsciously, I have left Zhongheng for more than a year. Faced with the constant negative news and the cliff-like decline of Zhongheng Group, I personally think that there should be more opportunities now, and I will pay attention to Zhongheng Group again. In my opinion, there are several reasons for concern and even optimism:

1, the core of fundamental investment has not changed. As an exclusive product of Class A medical insurance and essential drugs, the patent protection period of Zhongheng Xueshuantong is still very long (2006-2026), which has the market background that China is gradually entering an aging society.

2. It is said that the performance of Zhongheng Management 20 12 will only be better, not worse, and the gene of the company's recovery is still there. The divestiture of real estate business in the future will also be beneficial to the development of the company's main pharmaceutical industry and health food;

3, the biggest positive, the stock price! With the continuous emergence of the worst results and the stock price plunging caused by the full release of risks, the market value of Zhongheng, which is still promising, is far less than that of Chongqing pure beer, which completely failed in hepatitis B vaccine. As the saying goes, it can't get any worse, there comes a blackbird ... all this: this is just another cycle of greed and fear in investment ...;

4. Several "Zhongheng Famous Blogs" who have threatened to invest in Zhongheng Group for many years and nearly a year are said to have given up Zhongheng completely at "15 yuan".

At the same time, I think of some things from the termination of Zhongheng and Buchang, such as Yuheng Pharmaceutical, which has the title of "marketing expert", and its performance has been declining in recent years. As we all know, the pharmaceutical industry in China has been very dark. I have a doctor who has never invested in the pharmaceutical industry because of too much exposure. He thinks that bloody GDP makes his conscience uneasy, and China's medical reform has a long way to go. However, I am optimistic that the basic drug system is only the beginning. In the past, the marketing methods of "three abuses" in the pharmaceutical industry may become more and more unworkable. This may be one of the real reasons for the termination of step size and constant. The amazing interest chain in the middle is expected to be better controlled, which will help pharmaceutical companies with real competitive strength and excellent product quality to become bigger and stronger. So it is a good thing for the country and the people. I hope? This is not my wishful thinking.

The answer comes from the golden axe stock question and answer network